Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-11

FDA Approved: DENAVIR — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Denavir (penciclovir) filed by Mylan Pharmaceuticals, updating the regulatory status of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DENAVIR (PENCICLOVIR)

Snippet

SUPPL AP for DENAVIR (PENCICLOVIR)